Revelation Biosciences Warrant
REVBW
12 hedge funds and large institutions have $36.1K invested in Revelation Biosciences Warrant in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
73% more capital invested
Capital invested by funds: $20.9K → $36.1K (+$15.2K)
0% more funds holding
Funds holding: 12 → 12 (0)
7.81% less ownership
Funds ownership: 29.32% → 21.52% (-7.8%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$445 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$5.21K |
| 2 |
PVI
Pine Valley Investments
Marlton,
New Jersey
|
-$2.02K |
| 3 |
CAC
Cowen and Company
New York
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $9.09K | -$5.21K | -377,642 | -53% |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| $6.54K | – | – | – |
|
3
Walleye Capital
New York
| $4.96K | – | – | – |
|
|
PVI
4
Pine Valley Investments
Marlton,
New Jersey
| $3.84K | -$2.02K | -146,139 | -50% |
|
5
Walleye Trading
New York
| $2.78K | – | – | – |
|
|
CAC
6
Cowen and Company
New York
| $2.65K | -$3 | -200 | -0.2% |
|
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $1.91K | – | – | – |
|
8
Jane Street
New York
| $1.32K | – | – | – |
|
|
9
Citadel Advisors
Miami,
Florida
| $1.23K | +$445 | +32,266 | +226% |
|
|
PFM
10
Privium Fund Management
Amsterdam,
Netherlands
| $1.17K | – | – | – |
|
|
EPM
11
Equitec Proprietary Markets
Chicago,
Illinois
| $530 | – | – | – |
|
|
PIS
12
POM Investment Strategies
Raleigh,
North Carolina
| $27 | – | – | – |
|
REVBW Hedge Fund Activity: Q1 2024 in Review
12 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q1 2024, worth a combined $36.1K — up 73% from $20.9K a quarter earlier.
Fund positioning in REVBW was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $445. The largest seller was Linden Advisors, cutting an estimated $5.21K.
- 12 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $36.1K of Revelation Biosciences Warrant stock for Q1 2024, up 73% quarter-over-quarter.
- 0 funds opened new Revelation Biosciences Warrant positions in Q1 2024 and 0 closed out.
- The largest Revelation Biosciences Warrant buyer in Q1 2024 was Citadel Advisors, an estimated $445 added.
- The largest Revelation Biosciences Warrant seller in Q1 2024 was Linden Advisors, an estimated $5.21K sold.
Based on aggregated 13F filings for Q1 2024.